Vivani Medical (VANI) Current Assets (2014 - 2026)
Vivani Medical (VANI) posted quarterly Current Assets of $21.5 million for Q1 2026, up 45.1% year-over-year from $14.8 million in Q1 2025, and up 20.39% quarter-over-quarter from $17.9 million in Q4 2025.
Vivani Medical (VANI) Current Assets (2014 - 2026) Analysis & Trends
Vivani Medical's Current Assets history runs 13 years deep, the most recent figure standing at $21.5 million for Q1 2026.
- In Q1 2026, Current Assets rose 45.1% year-over-year to $21.5 million; the TTM figure through Mar 2026 stood at $21.5 million (up 45.1% YoY), while the FY2025 annual figure was $17.9 million, down 12.44% from the prior year.
- Current Assets for Q1 2026 stood at $21.5 million, up from $17.9 million in the prior quarter.
- The five-year high for Current Assets was $60.2 million in Q1 2022, with the low at $4.2 million in Q3 2025.
- The 5-year median for Current Assets is $26.3 million (2024), against an average of $30.4 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 1824.99% in 2022, then slumped 80.49% in 2025.
- Vivani Medical's Current Assets stood at $47.5 million in 2022, then tumbled by 51.48% to $23.1 million in 2023, then fell by 11.36% to $20.4 million in 2024, then decreased by 12.44% to $17.9 million in 2025, then climbed by 20.39% to $21.5 million in 2026.
- Business Quant data shows VANI's Current Assets at $21.5 million in Q1 2026, $17.9 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | 21.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.64 Mn |
| Mar 31, 2026 | 21.55 Mn |
| Dec 31, 2025 | 17.90 Mn |
| Sep 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 8.72 Mn |
| Mar 31, 2025 | 14.85 Mn |
| Dec 31, 2024 | 20.44 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Jun 30, 2024 | 26.34 Mn |
| Mar 31, 2024 | 31.50 Mn |
| Dec 31, 2023 | 23.06 Mn |
| Sep 30, 2023 | 30.68 Mn |
| Jun 30, 2023 | 36.22 Mn |
| Mar 31, 2023 | 40.68 Mn |
| Dec 31, 2022 | 47.53 Mn |
| Sep 30, 2022 | 54.46 Mn |
| Jun 30, 2022 | 57.39 Mn |
| Mar 31, 2022 | 60.22 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 73.22 Mn |